The compound showed good liver microsomal stability, poor antiproliferative effect against FLT3-wt tumor cells, low toxicity to normal cells and weaker inhibitory activity against c-KIT compared with the FLT3 inhibitor gilteritinib in a zebrafish model. The gene discussed is FLT3; the disease is neoplasm.